Accelerating Science: How to cure the incurable with cell and gene therapy

Application Note: Cardiotoxicity of iCell® Cardiomyocytes Using the CyBi®-SELMA 96, 250 μl Semi-automated Pipettor
3 December 2013

In this study, a 96, 250 μl semi-automated pipettor from CyBio AG was evaluated through media changes and compound dosing in a cell viability assay. The assay tests the cardiac cytotoxicity of a series of compounds on the viability of iCell® Cardiomyocytes.